Lv6
2940 积分 2022-02-16 加入
Overview of PROTACs Targeting the Estrogen Receptor: Achievementsfor Biological and Drug Discovery
25天前
已完结
Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design
26天前
已完结
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
1个月前
已完结
25LBA Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) + vemurafenib (VEM) in the phase 3 coBRIM study
1个月前
已关闭
The state of the art in secondary pharmacology and its impact on the safety of new medicines
1个月前
已完结
Atropisomerism in Medicinal Chemistry: Challenges and Opportunities
2个月前
已完结
Prolonged and tunable residence time using reversible covalent kinase inhibitors
2个月前
已完结
Insight into the Structural Features of Pyrazolopyrimidine‐ and Pyrazolopyridine‐based B‐RafV600E Kinase Inhibitors by Computational Explorations
3个月前
已完结
Protection for the Amino Group
3个月前
已完结
Protection for Phenols and Catechols
3个月前
已完结
皖公网安备34019202002308
